Astria Therapeutics Inc

NASDAQ:ATXS   4:00:00 PM EDT
13.49
-0.18 (-1.32%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Astria Therapeutics Inc Stock, NASDAQ:ATXS

75 State Street, Suite 1400, Boston, Massachusetts 02110
United States of America
Phone: +1.617.349.1971
Number of Employees: 29

Description

Astria Therapeutics, Inc. engages in the discovery, development, and commercialization of novel therapeutics. Its lead product candidate is STAR-0215, which is intended to treat Hereditary Angioedema, a rare genetic disorder characterized by severe, recurrent, unpredictable, painful, and sometimes life-threatening swelling in the face, limbs, abdomen, and airway. The company was founded by Michael R. Jirousek, Jill C. Milne and Steven E. Shoelson on June 26, 2008 and is headquartered in Boston, MA.